Public Profile

Pharmatech Asia Group

Pharmatech Asia Group, headquartered in China, is a leading player in the pharmaceutical and biotechnology industry, specialising in innovative health solutions. Founded in the early 2000s, the company has established a strong presence across Asia, focusing on research and development, manufacturing, and distribution of high-quality pharmaceutical products. With a diverse portfolio that includes nutraceuticals, dietary supplements, and advanced drug formulations, Pharmatech Asia Group stands out for its commitment to quality and efficacy. The company has achieved significant milestones, including regulatory approvals and partnerships that enhance its market position. Renowned for its cutting-edge technology and rigorous quality control processes, Pharmatech Asia Group continues to drive advancements in health and wellness, making it a trusted name in the industry.

DitchCarbon Score

How does Pharmatech Asia Group's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

0

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

Pharmatech Asia Group's score of 0 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.

26%

Pharmatech Asia Group's reported carbon emissions

Pharmatech Asia Group, headquartered in China, currently does not have available carbon emissions data for the most recent year, nor do they have specified reduction targets or climate pledges. This absence of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting practices. In the context of the pharmaceutical industry, it is increasingly important for companies to establish clear emissions reduction strategies and transparency in reporting to align with global climate goals. As the industry moves towards sustainability, Pharmatech Asia Group may need to consider developing and communicating its climate initiatives to enhance its environmental responsibility and stakeholder engagement.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Pharmatech Asia Group's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Pharmatech Asia Group is headquartered in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Pharmatech Asia Group is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

HBJR Holdings Ltd.

CA
Health Services
Updated 3 days ago

Menshed

AU
Health Services
Updated 2 days ago

Drager Argentina S.A.

AR
Health Services
Updated 3 days ago

Wedar Group

CN
Health Services
Updated 10 days ago

CLAIR LOGIS

BE
Health Services
Updated 10 days ago

Integrated Diagnostics Holdings - IDH

EG
Health Services
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers